Cefixime and Clavulanic Acid Tablets | Recefix-CV

PRODUCT NAME : Cefixime and Clavulanic Acid Tablets

Dosage Form: Tablets

Recefix-CV is a pharmaceutical formulation developed with a combination of Cefixime and Clavulanic Acid. These two active ingredients work together to support the treatment of certain bacterial infections when prescribed by a healthcare professional.

Cefixime belongs to the cephalosporin group of antibiotics. It works by interfering with bacterial cell wall formation, which helps stop bacterial growth. Clavulanic Acid acts as a beta-lactamase inhibitor. It helps protect Cefixime from certain enzymes produced by resistant bacteria, allowing the antibiotic to work more effectively against susceptible organisms.

Cefixime and Clavulanic Acid Tablets may be prescribed for selected bacterial infections affecting different parts of the body, depending on the infection type and bacterial sensitivity. The combination offers an additional approach to managing infections where beta-lactamase-producing bacteria may be involved.

Recefix-CV is developed for pharmaceutical distribution and healthcare markets under the BIOMORPH brand. Its formulation combines two established pharmaceutical ingredients in a convenient tablet dosage form.

The medicine should be used only on the advice of a qualified healthcare professional. Patients should follow the prescribed course and avoid using antibiotics without medical guidance. Proper antibiotic use is important for reducing the risk of antimicrobial resistance.